Replies to post #121988 on PharmaCyte Biotech Inc (PMCB)

[rcstock]

Agree oldmusky with much of your post.
Very poor management. In my job in Aerospace, I dealt with many PHDs.
While most were very smart, they were usually very poor managers. I see some of that here. They could have done the "rabbit test" Months ago as an example. Maybe we'll be lucky if not good. Holding till the end.

[DragonBear]

Dilution. Since I have been invested here they have increased the share total by %50

Dilution is never a problem in Microcraps, until after it happens.

This may be the best test around

It isn't. It's equivalent to many of the tests already in the market.

but it is too costly to send to lab and wait for results... My prediction is the test makes it through the FDA but is never widely used.

Cost is probably not an issue. It won't be used widely simply because the market is already saturated with test kits. Kenny has timed his PR pumps well. By the time the test is validated, and a sales force company is contracted in, it could be easily approaching Jul. Any revenue trickling in for Aug-Oct won't be reported till 23-DEC (NT included). So Kenny has till Dec to pump away about it.

Facet Life Sciences(FLS) and the IND. I have no idea how much FLS has been compromised by the Covid outbreak but I believe they probably are.

There's nothing Facet employees can't do working from home. One could make the case, Facet isn't doing the work for FREE. Has Kenny paid them?

I am more concerned that the company announces yet more tests that further delays the IND

That seed Kenny has already planted. While SHs swoon over Covid test kits till Dec, all IND delays will be blamed on Covid. Including tests which should've been completed months ago.